Dietary Supplements

A dietary supplement is defined as a product taken by mouth containing a dietary ingredient intended to supplement the diet. Dietary ingredients include vitamins, minerals, herbs or other botanicals, and amino acids.

Select an Issue

Dietary Supplement Resource Library

Explore our list of resources to learn more about the dietary supplement category and how it is regulated by the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC).

Explore
Woman Shopping for Dietary supplements
Dietary Supplements Access Act

The Dietary Supplements Access Act of 2023 is bipartisan legislation intended to give American consumers increased flexibility to best determine how to use their pre-tax dollars to stay healthy.

three different kinds of dietary supplement capsules
Explaining the Regulatory Framework for Dietary Supplements

It’s a common misconception that the dietary supplements category is not regulated, when in fact it is regulated by multiple government agencies, with manufacturers and retailers also managing responsibility throughout the process.

Sep 28, 2021

Browse Dietary Supplements Content

Weekly Voice Teaser

Weekly Voice

Congress Remains Uncertain After 2022 Midterm Elections

Nov 11, 2022

Weekly Voice Teaser

Weekly Voice

Mid-Term Elections Expand One-Party Control in Several States

Nov 11, 2022

Federal Register Notice graphic image with flag, capitol building, and gavel

Weekly Voice

Federal Register (FR) Notices, November 7, 2022

Nov 10, 2022

Orange CHPA logo on dark blue background

Press Releases and Statements

CHPA Responds to Four-Week Cholesterol Study Comparing Supplements to Prescription Statin Drug

Consumer Healthcare Products Association (CHPA) responds to findings from the “Supplements, Placebo, or Rosuvastatin (SPORT)” Study published in the Journal of the American College of Cardiology.

Nov 6, 2022

DS Digest Teaser

Dietary Supplements Digest

Dietary Supplement State and Local Issues- Nov. 4, 2022

Nov 4, 2022

Federal Register Notice graphic image with flag, capitol building, and gavel

Weekly Voice

Federal Register (FR) Notices, October 24, 2022

Oct 28, 2022

Test Tubes

Press Releases and Statements

Landmark Paper Published in Regulatory Journal Proposes Safety Assessment Parameters for Probiotics

Jay Sirois, PhD, CHPA’s vice president of regulatory & scientific affairs, and co-author of the paper, Considerations for determining safety of probiotics: A USP perspective

Oct 27, 2022

Federal Register Notice graphic image with flag, capitol building, and gavel

Weekly Voice

Federal Register (FR) Notices, October 10, 2022

Oct 10, 2022

U.S. Capitol East Facade in the morning

Press Releases and Statements

CHPA Statement Regarding Congressional Passage of Continuing Resolution to Reauthorize FDA User Fee Programs

(WASHINGTON, DC) – Consumer Healthcare Products Association (CHPA) President and CEO, Scott Melville, today released the below statement following congressional passage of a short-term spending package to fund the Federal Government through Dec. 16. Included in this Continuing Resolution is legislation to reauthorize the U.S. Food and Drug Administration’s (FDA) user fee programs for prescription drugs, generic drugs, biosimilars, and medical devices over the next five years.

Sep 30, 2022

FDA headquarters sign in Washington DC

Submission

Comments to FDA: Remote Regulatory Assessments Draft Guidance

Sep 30, 2022

Filter Results

On Capitol Hill

CHPA is a proud supporter of the Congressional Dietary Supplement Caucus (DSC), a bipartisan forum for the exchange of ideas and information regarding dietary supplements in the U.S. House of Representatives and the Senate.

Learn More